Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants

View source ↗

Summary

This clinical trial update describes a study evaluating the natural history and oncological risk in pediatric patients with pathogenic PTEN variants (PTEN hamar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: PTEN Hamartoma Syndrome | Status: RECRUITING